These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 20697822

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C, Greenawalt DM, Kowalczyk A, Ciavarella ML, Raskutti G, Murray WK, Phillips WA, Thomas RJ.
    Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
    [Abstract] [Full Text] [Related]

  • 24. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
    Blackham AU, Yue B, Almhanna K, Saeed N, Fontaine JP, Hoffe S, Shridhar R, Frakes J, Coppola D, Pimiento JM.
    J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [Abstract] [Full Text] [Related]

  • 29. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [Abstract] [Full Text] [Related]

  • 30. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y.
    J Surg Oncol; 2009 Nov 01; 100(6):442-6. PubMed ID: 19653262
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
    Nakamura T, Hayashi K, Ota M, Eguchi R, Ide H, Takasaki K, Mitsuhashi N.
    Am J Surg; 2004 Sep 01; 188(3):261-6. PubMed ID: 15450831
    [Abstract] [Full Text] [Related]

  • 36. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?
    Tougeron D, Scotté M, Hamidou H, Di Fiore F, Paillot B, Michot F, Michel P.
    J Surg Oncol; 2012 Jun 15; 105(8):761-6. PubMed ID: 22124932
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
    Girvin GW, Matsumoto GH, Bates DM, Garcia JM, Clyde JC, Lin PH.
    Am J Surg; 1995 May 15; 169(5):557-9. PubMed ID: 7747839
    [Abstract] [Full Text] [Related]

  • 40. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H, Farrell JJ, Crane CH.
    J Gastroenterol Hepatol; 2009 May 15; 24(5):708-10. PubMed ID: 19646012
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.